Cerebrospinal fluid electrolyte changes during lateral ventricular perfusion with noradrenaline and associated cardiovascular responses.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002118:Calcium / Q000134:cerebrospinal fluid; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D002552:Cerebral Ventricles / Q000187:drug effects*; D004573:Electrolytes / Q000134:cerebrospinal fluid*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D008274:Magnesium / Q000134:cerebrospinal fluid; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D010477:Perfusion; D011188:Potassium / Q000134:cerebrospinal fluid; D012964:Sodium / Q000134:cerebrospinal fluid; D014149:Tranquilizing Agents / Q000494:pharmacology
D004573:Electrolytes; D014149:Tranquilizing Agents; D012964:Sodium; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine